Startseite>>Signaling Pathways>> Chromatin/Epigenetics>> DNA/RNA Methylation>>3-Methylcytidine (methosulfate)

3-Methylcytidine (methosulfate)

Katalog-Nr.GC18509

3-Methylcytidine (methosulfate) is a cytidine derivative used as an internal standard for HPLC.

Products are for research use only. Not for human use. We do not sell to patients.

3-Methylcytidine (methosulfate) Chemische Struktur

Cas No.: 21028-20-6

Größe Preis Lagerbestand Menge
10mg
44,00 $
Auf Lager
25mg
82,00 $
Auf Lager
50mg
110,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

3-Methylcytidine (methosulfate) is a cytidine derivative used as an internal standard for HPLC. 3-Methylcytidine is a common epigenetic modification in tRNA but its role in the cell has not been defined.[1] 3-Methylcytidine has been investigated as a potential biomarker for cancer and was significantly elevated in the urine of breast cancer patients.[2]

Reference:
[1]. D'Silva, S., Haider, S.J., and Phizicky, E.M. A domain of the actin binding protein Abp140 is the yeast methyltransferase responsible for 3-methylcytidine modification in the tRNA anti-codon loop. RNA 17(6), 1100-1110 (2011).
[2]. Hsu, W.Y., Chen, C.J., Huang, Y.C., et al. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese. PLoS One 8(12), 1-8 (2013).

Bewertungen

Review for 3-Methylcytidine (methosulfate)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 3-Methylcytidine (methosulfate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.